Award of 1 million base pairs of DNA to support innovation in the industrial application of synthetic biology
“We are honored that our project was selected for this year’s G-Prize. Deciphering the full connectivity guided by protein-protein interactions requires synthetic approaches that scale beyond current methods,” said Isaacs. “The 1 million base pairs of DNA from Gen9 will allow us to re-encode larger subsets of biomolecular interactions and create a first-of-its-kind data set that we believe will help guide future studies of kinase signaling and potentially yield new drug targets.”
Gen9 has developed unique, next-generation technologies for synthesizing and assembling DNA constructs for use in numerous synthetic biology applications, including antibody, peptide and enzyme engineering; gene and pathway building; and genome construction. Today, Gen9 is manufacturing and shipping double-stranded GeneBits™, GeneBytes™, and GeneBytes Plus™ DNA constructs, or gene fragments from 500 to 10,000 base pairs long. The company’s innovative BioFab® platform has the capacity to generate tens of thousands of synthetic gene fragments per year in just a few square feet of laboratory space.
“This year’s G-Prize represents the single largest award of synthetic DNA constructs ever granted from a commercial entity to an individual research lab,” said
The G-Prize contest, conceived and exclusively sponsored by Gen9, was launched to foster creative and innovative approaches for using synthetic DNA to advance industries including chemical and enzyme production, biofuels, pharmaceuticals, and even data storage. Contestants submitted applications describing their breakthrough ideas for using gene constructs, and those entries were judged by a panel of experts chosen by Gen9. The 2013 G-Prize awarded one winner a free library of DNA constructs equaling 1 million base pairs. Each DNA construct manufactured by Gen9 is a double-stranded gene fragment from 500 to 10,000 base pairs in length. Based on the current average market cost of similar DNA constructs, the total market value of this year’s prize exceeds
For more information about the G-Prize and its winners, please visit www.gen9bio.com.
Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. The Gen9 technology allows for the lowest-cost and highest-quality DNA constructs commercially available. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is powering the synthetic biology revolution from our headquarters in
Gen9, GeneBits, GeneBytes and BioFab are trademarks or registered trademarks of
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Apple, HP, Intel May Take a Hit from Slowdown in Smartphone Sales Growth
- FDIC Files Lawsuit on Behalf of Banks Allegedly Hurt by Libor Scandal
- Some California Cities Seeking Water Independence
- SoCalGas Reaches Record Spend on Diversity Suppliers
- Motley Crue's Nikki Sixx Marries Model Courtney Bingham
- Chinese e-Commerce Giant Alibaba Gears for IPO in U.S.
- Will Missing Malaysian Jet Prompt Aviation System Change?
- GM Recall Poses First Major Test for New CEO
- Obama Seeks to Stay Neutral in CIA-Senate Conflict